Core Viewpoint - Hema Medical (03309.HK) announced a share buyback of 430,000 shares at a cost of HKD 625,000, with a buyback price ranging from HKD 1.43 to HKD 1.50 per share [1] Summary by Category - **Company Actions** - The company executed a buyback of 430,000 shares, indicating a strategic move to enhance shareholder value [1] - The total expenditure for the buyback was HKD 625,000, reflecting the company's commitment to returning capital to shareholders [1] - **Financial Details** - The buyback price per share was set between HKD 1.43 and HKD 1.50, which may suggest the company's valuation perspective on its own shares [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 希瑪醫療控股有限公司 呈交日期： 2026年2月4日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 若購回/贖回股份將於期終結存日期之後購回/贖回結算完成之時予以註銷，則該等購回/贖回股份仍屬A部所述期終結存當日的已發行股份的一部分。該等購回/贖回股份的詳情應在B部作 出披露。 第 2 頁 共 6 頁 v 1.3.0 第一章節註釋： 若股份曾以超過一個每股價格發行/出售/購回/贖回，則須提供每股成交量加權平均價格。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所 ...

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Hema Medical (03309.HK) by 10,000 shares on February 2, with a total net reduction of 874,000 shares over the last five trading days and 1,688,000 shares over the last twenty trading days [1][2] - As of now, southbound funds hold 73,703,000 shares of Hema Medical, which accounts for 5.97% of the company's total issued ordinary shares [1] Group 2 - Hema Medical Holdings Limited, formerly known as Hema Eye Medical Holdings Limited, is primarily engaged in providing medical services through four business segments [2] - The Hong Kong medical business segment focuses on offering ophthalmology, dentistry, and other medical services, as well as selling vision aids [2] - The mainland dental business segment is dedicated to providing dental services in mainland China [2] - The medical consumables sales segment is involved in selling medical consumables in Hong Kong [2] - The mainland ophthalmology business segment provides ophthalmology services and sells vision aids in mainland China [2]

截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 希瑪醫療控股有限公司 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03309 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 8,000,000,000 | HKD | | 0.1 | HKD | | 800,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 8,000,000,000 | HKD | | 0.1 | HKD | | 800,000,000 | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 本月底法定/註冊股本 ...

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Hema Medical (03309.HK) by 644,000 shares on January 28, with a total net reduction of 680,000 shares over the past five trading days and 1,708,000 shares over the past 20 trading days [1] - As of now, southbound funds hold 73,913,000 shares of Hema Medical, accounting for 5.99% of the company's total issued ordinary shares [1] Group 2 - Hema Medical Holdings Limited, formerly known as Hema Eye Medical Holdings Limited, is primarily engaged in providing medical services through four operational segments [2] - The Hong Kong medical segment focuses on offering ophthalmology, dentistry, and other medical services, as well as selling vision aids [2] - The mainland dental segment is dedicated to providing dental services in mainland China [2] - The medical consumables sales segment is involved in selling medical consumables in Hong Kong [2] - The mainland ophthalmology segment provides ophthalmology services and sells vision aids in mainland China [2]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Hema Medical (03309.HK) by 10,000 shares on January 8, with a total net reduction of 390,000 shares over the past five trading days and 1,546,000 shares over the past 20 trading days [1] - As of now, southbound funds hold 75,161,000 shares of Hema Medical, which accounts for 6.09% of the company's total issued ordinary shares [1] Group 2 - Hema Medical Holdings Limited, formerly known as Hema Eye Medical Holdings Limited, is primarily engaged in providing medical services through four business segments [2] - The Hong Kong medical business segment focuses on offering ophthalmology, dentistry, and other medical services, as well as selling vision aids [2] - The mainland dental business segment is dedicated to providing dental services in mainland China [2] - The medical consumables sales segment primarily involves selling medical consumables in Hong Kong [2] - The mainland ophthalmology business segment focuses on providing ophthalmology services and selling vision aids in mainland China [2]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 希瑪醫療控股有限公司 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03309 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 8,000,000,000 | HKD | | 0.1 | HKD | | 800,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 8,000,000,000 | HKD | | 0.1 | HKD | | 800,000,000 | FF301 FF3 ...

希玛医疗(03309)发布公告，于2025年12月29日，该公司斥资58.07万港元回购34万股。 ...

Core Viewpoint - Hema Medical (03309.HK) announced a share buyback plan, indicating a strategic move to enhance shareholder value through repurchasing shares at a price range of HKD 1.69 to HKD 1.74 per share [1] Group 1 - The company plans to spend HKD 580,700 to repurchase 340,000 shares [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 希瑪醫療控股有限公司 呈交日期： 2025年12月29日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 03309 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | | | | | 每股發行/出售價 (註4) | 已發行股份總數 | | | | 已發 ...